ControlRad announced today that it made several additions to its leadership team, naming a new chief financial officer, VP of U.S. operations, VP of marketing and two new VPs of sales.
The Atlanta-based company named Peter Pizzo as its new CFO. Pizzo has more than 25 years of experience in senior financial roles, having previously served as CFO at Cartiva before it was purchased by Wright Medical (NSDQ:WMGI).
Amy Lazarus was tabbed as the new VP of U.S. operations, having previously held several roles at General Electric (NYSE:GE), including general manager of the interventional service business. The company also named former Zimmer Biomet (NYSE:ZBH) spine division general manager Joe Ross as its new VP of marketing.
ControlRad also selected Sean Finnerty and Timothy Hein as area VP of sales in the east and west, respectively. Finnerty previously served as national sales manager at Cartiva, while Hein was VP of sales for Paradigm Spine before it was acquired by RTI Surgical (NSDQ:RTIX).
Pizzo and Finnerty are the second and third former Cartiva employees to join ControlRad in recent months after the company added former Cartiva co-founder & CEO Tim Patrick to its board in October after collecting $15 million in a Series B funding round.
“2019 was a significant year for ControlRad, with FDA clearance and initial installations of our first product,” ControlRad CEO Guillaume Bailliard said in a news release. “The wealth of experience that Peter, Amy, Joe, Sean and Tim bring in introducing new products to the market will be invaluable as we ramp up commercialization for ControlRad Trace in 2020.”
The ControlRad Trace is an FDA-approved device for reducing radiation in fluoroscopically guided procedures. The system uses a proprietary semi-transparent filter, along with its tablet and image processing technology for retrofitting on existing C-arms in radiation reduction. It’s designed to allow medical professionals to draw a region of interest on the ControlRad tablet, which optimizes image quality in that area while reducing radiation in the periphery.
The Trace system is the first FDA-cleared technology that can be integrated into existing mobile C-arms to reduce the ionizing radiation that can occur in fluoroscopically guided procedures. The Trace technology reduces radiation exposure by up to 89%, according to previous clinical trials.